IL6 and type 2 diabetes mellitus: Whilst serum levels of sIL-6Rα are the same for T2DM and NDM patients, the elevation in circulating IL-6 means that plasma levels of the IL-6/sIL-6Rα complex are increased in diabetic patients [75], raising the likelihood of the signalling pathway being inappropriately activated.